Marvin Woodall (Thrombolex)
Overview
Marvin Woodall is a prominent figure in the medical device industry, known particularly for his role at Thrombolex, Inc., a company he co-founded. Woodall has held the position of Executive Chairman and has been instrumental in Thrombolex's growth and innovation in endovascular catheter technology, specifically targeting arterial and venous thromboembolic (VTE) conditions. His career span includes significant achievements at Johnson & Johnson, where he contributed to the development and commercialization of major cardiovascular devices.
Recent Developments
In the past few years, Marvin Woodall has transitioned roles at Thrombolex, marking significant structural changes within the company:
- July 2022: Michael Cerminaro was appointed as CEO of Thrombolex, succeeding Marvin Woodall. Woodall remains as Executive Chairman, a move aligning with Thrombolex’s strategic direction to push forward with commercial-stage innovations in medical devices (source 1).
- October 2024: Woodall continued to guide strategic initiatives at Thrombolex, emphasizing the development and marketing of FDA-cleared products derived from the BASHIR™ Endovascular Catheter (source 2).
- During his ongoing tenure, Woodall has focused on the commercialization of Thrombolex’s innovative catheters designed to provide enhanced treatment for clotting conditions, achieving multiple FDA clearances and expanding the company's product offerings.
Personal Information
| Attribute | Information |
|---|---|
| Full Name | Marvin Woodall |
| Born | Not publicly available |
| Nationality | American |
| Occupation | Co-Founder, Executive Chairman at Thrombolex |
| Known For | Medical device innovation, leadership in cardiovascular health |
| Net Worth | Not publicly available |
| Education | University of Oklahoma, Harvard University, Columbia University |
Early Life and Education
Marvin Woodall's educational background laid the foundation for his extensive career in medical device innovation. He obtained a Bachelor’s in Business Administration from the University of Oklahoma. Furthering his skills, he attended executive management courses at Harvard University and Columbia University, focusing on strategic leadership and international operations management. These academic pursuits equipped Woodall with the competencies to excel in high-level management roles, facilitating his contributions to major achievements in medical technology.
Career and Notable Achievements
Marvin Woodall’s professional journey is marked by pioneering advancements in medical technology:
- Johnson & Johnson: Over a 37-year tenure, Woodall played a pivotal role in launching the world's first balloon-expandable coronary stent and the first drug-eluting stent while serving at Johnson & Johnson Interventional Systems.
- Thrombolex: As a co-founder, Woodall transitioned Thrombolex from a startup into a commercial-stage company recognized for its innovative solutions in treating thromboembolic diseases. Under his leadership, the BASHIR™ Endovascular Catheter received multiple FDA clearances.
Current Work and Impact
Currently, Marvin Woodall serves as the Executive Chairman of Thrombolex. His leadership continues to influence the strategic direction of the company, focusing on expanding the adoption and effectiveness of Thrombolex’s catheter technology. Woodall’s work impacts cardiovascular healthcare by providing physicians with tools that significantly improve patient outcomes in the treatment of VTE diseases.
Conclusion
Marvin Woodall's contribution to the medical device industry through his work at Thrombolex has been substantial. His expertise and leadership have not only shaped the success of Thrombolex but have also advanced the treatment of thromboembolic diseases. As Thrombolex continues to innovate under new leadership, Woodall's legacy of commitment to medical excellence and innovation will likely influence future developments in endovascular technology.